BO’s Act
Summary
What This Bill Does
BO's Act directs HHS to conduct a Public Health Service Act study on home cardiorespiratory monitors for infants. Within one year, HHS must report to Congress on evidence about the effectiveness, performance, and accuracy of home monitors that track heart rate, blood oxygen, and other vital signs; models of care that could improve the home sleeping environment for infants; criteria health plans use to determine when monitors are medically appropriate; and recommendations on whether the monitors have sufficient product efficacy to support public or private insurance coverage. The bill does not mandate coverage directly, but it creates the evidentiary record Congress and insurers could use for future coverage decisions.
Who Benefits and How
Infants at risk of sudden unexpected infant death benefit if the study clarifies whether home monitors improve detection or care. Parents of high-risk infants benefit from federal review of monitor accuracy, care models, and coverage criteria. Pediatric clinicians benefit from a consolidated HHS assessment of monitor evidence and medically appropriate use. Medical device manufacturers benefit if the report identifies evidence supporting public or private insurance coverage.
Who Bears the Burden and How
HHS must conduct the study and deliver a report to Congress within one year. Health plans may face scrutiny over criteria used to decide whether infant home monitors are medically appropriate. Monitor manufacturers with weak evidence may face unfavorable federal findings on efficacy or accuracy. Congress must decide whether to act on any coverage or care-model recommendations in the report.
Key Provisions
- Requires an HHS study of home cardiorespiratory monitors for infants.
- Directs review of effectiveness, performance, and accuracy for heart rate, blood oxygen, and other vital signs.
- Requires analysis of care models to improve the home sleeping environment.
- Requires review of health plan criteria for medically appropriate monitor coverage.
- Requires recommendations on whether monitor efficacy supports public or private insurance coverage.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
Requires HHS to study and report to Congress on the effectiveness, accuracy, coverage criteria, and care models for home cardiorespiratory monitors used with infants at risk of sudden unexpected infant death.
Key Policy Areas
Health Care, Infant Health, Insurance Coverage, Medical Devices
Primary Purpose
Requires HHS to study and report to Congress on the effectiveness, accuracy, coverage criteria, and care models for home cardiorespiratory monitors used with infants at risk of sudden unexpected infant death.
Policy Domains
Resolution provisions
Identified Gains
- Infants at risk of sudden unexpected infant death
- Parents of high-risk infants
- Pediatric clinicians
- Medical device manufacturers
Identified Costs
- HHS
- Health plans
- Monitor manufacturers with weak evidence
- Congress
Sponsors
Legislative Progress
In CommitteeMr. Yakym introduced the following bill; which was referred to …
Referred to the House Committee on Energy and Commerce.
Introduced in House
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Health plans, Infants at risk of sudden unexpected infant death, Parents of high-risk infants
Positive-direction: Infants at risk of sudden unexpected infant death
Negative-direction: Health plans
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology